Literature DB >> 14718629

The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus.

Michael A Calderwood1, Kersten T Hall2, David A Matthews3, Adrian Whitehouse1.   

Abstract

The herpesvirus saimiri (HVS) ORF73 gene product shares limited homology with the ORF73 protein of Kaposi's sarcoma-associated herpesvirus (KSHV). ORF73 is expressed in an in vitro model of HVS latency, where the genome persists as a non-integrated circular episome. This suggests it may have a similar role to KSHV ORF73 in episomal maintenance, by tethering viral genomes to host-cell chromosomes. Here, the association of ORF73 with host mitotic chromosomes is described. Deletion analysis demonstrates that the distal 123 aa of the ORF73 protein are required for mitotic chromosomal localization and for self-association. Moreover, deletion of the extreme C terminus disrupts both self-association and host mitotic chromosome colocalization. This suggests that HVS ORF73 has a similar role to KSHV ORF73 in episomal maintenance and that association of ORF73 to host mitotic chromosomes is dependent on its ability to form multimers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718629     DOI: 10.1099/vir.0.19437-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

Review 1.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

2.  Whole-genome transcription profiling of rhesus monkey rhadinovirus.

Authors:  Dirk P Dittmer; Carlos M Gonzalez; Wolfgang Vahrson; Scott M DeWire; Rebecca Hines-Boykin; Blossom Damania
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  The insulator protein CTCF binding sites in the orf73/LANA promoter region of herpesvirus saimiri are involved in conferring episomal stability in latently infected human T cells.

Authors:  Katrin Zielke; Florian Full; Natascha Teufert; Monika Schmidt; Ingrid Müller-Fleckenstein; Barbara Alberter; Armin Ensser
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

4.  Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2.

Authors:  Rhoswyn Griffiths; Adrian Whitehouse
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

5.  Histone modification pattern of the T-cellular Herpesvirus saimiri genome in latency.

Authors:  Barbara Alberter; Armin Ensser
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

6.  Genome-wide histone acetylation profiling of Herpesvirus saimiri in human T cells upon induction with a histone deacetylase inhibitor.

Authors:  Barbara Alberter; Benjamin Vogel; Doris Lengenfelder; Florian Full; Armin Ensser
Journal:  J Virol       Date:  2011-03-23       Impact factor: 5.103

7.  Potential of herpesvirus saimiri-based vectors to reprogram a somatic Ewing's sarcoma family tumor cell line.

Authors:  Hannah F Brown; Christian Unger; Adrian Whitehouse
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

8.  Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence.

Authors:  Aline C Habison; Chantal Beauchemin; J Pedro Simas; Edward J Usherwood; Kenneth M Kaye
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

9.  The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.

Authors:  Ammy Lin; Shan Wang; Tin Nguyen; Kathy Shire; Lori Frappier
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

10.  Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73.

Authors:  Jiayu Gao; Judy M Coulson; Adrian Whitehouse; Neil Blake
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.